A Phase III, Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hyperactivity Disorder in School-age Children
Titel:
A Phase III, Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hyperactivity Disorder in School-age Children
Auteur:
Nasser, Azmi Liranso, Tesfaye Adewole, Toyin Fry, Nicholas Hull, Joseph T. Chowdhry, Fatima Busse, Gregory D. Cutler, Andrew J. Jones, Nandita Joshi Findling, Robert L. Schwabe, Stefan